SRC TR-13-045

HPV2 TEST RULE DATA ADEQUACY REVIEW: JUNE 2013 UPDATE (FINAL)

D-gluco-heptonic acid, monosodium salt, (2.xi.)-, CASRN 31138-65-5

Prepared by:

Megan Nelson, Amy Nguyen, Julie Ramage, Lisa Ingerman, Teresa Manyin, 

and William Richards

Defense and Environmental Solutions Division

SRC, Inc.

7502 Round Pond Road

North Syracuse, NY 13212

Contract No. EP-W-09-027

Task FG007.3.009.001

Submitted to:

OCSPP/OPPT/RAD (7403M)

U.S. Environmental Protection Agency

1200 Pennsylvania Avenue

Washington, D.C. 20460

Bryan Lobar, Project Officer

David Brooks, Work Assignment Manager

Amy Benson, Alternate Work Assignment Manager

June 13, 2013
Final HPV2 Chemical Data Adequacy Review (June 2013) CASRN 31138-65-5

i

TABLE OF CONTENTS

A. SOURCE MATERIAL USED FOR ASSESSMENT .............................................................. 1

B. EVALUATING DATA ADEQUACY ..................................................................................... 2

C. SUMMARY OF DATA ADEQUACY FOR TESTING REQUIRED BY TEST RULE ........ 2

D. DATA FOR SIDS ENDPOINTS.............................................................................................. 4

D-1. Acute Toxicity to Fish ....................................................................................................... 4

D-2. Toxicity to Aquatic Plants ............................................................................................... 11

D-3. Acute Toxicity.................................................................................................................. 18

D-4. Genetic Toxicity – Gene Mutation................................................................................... 21

D-5. Genetic Toxicity – Chromosomal Aberrations................................................................ 25

E. DATA ADEQUACY SUMMARY TABLE........................................................................... 30
Final HPV2 Chemical Data Adequacy Review (June 2013) CASRN 31138-65-5

1

A. SOURCE MATERIAL USED FOR ASSESSMENT

This document evaluates five submissions from Harcros Chemicals, Inc. (submissions dated

from December 18, 2012 to April 24, 2013) that contain data from toxicity testing of D-glucoheptonic acid, monosodium salt, (2.xi.)- (CASRN 31138-65-5) and were received by EPA in 

response to the final test rule, “Testing of Certain High Production Volume Chemicals; Second 

Group of Chemicals” (76 FR 1067, January 7, 2011; referred to herein as HPV2; available online 

at http://www.regulations.gov/#!documentDetail;D=EPA-HQ-OPPT-2007-0531-0579 as of June 

13, 2013). 

The HPV2 test rule requires testing with CASRN 31138-65-5 for the following toxicological

endpoints: C1 (consisting of acute toxicity to fish, acute toxicity to Daphnia, and toxicity to 

algae testing if log Kow < 4.2 or chronic toxicity to Daphnia and toxicity to algae testing if log 

Kow ≥ 4.2), D (acute mammalian toxicity test), E1 (bacterial reverse mutation test), E2 

(chromosomal aberration or micronucleus test), and F1 (combined repeated dose toxicity study 

with the reproduction/developmental toxicity screening test). Since the log Kow of CASRN 

31138-65-5 is estimated to be -6.441, which is < 4.2, the C1 aquatic toxicity testing requirement 

is considered to include acute toxicity to fish, acute toxicity to Daphnia, and toxicity to algae 

testing.

The submissions from Harcros Chemicals, Inc. included the following: 

Acute Toxicity to Rainbow Trout, submitted for C1 testing requirement on April 24, 

2013 (available online at http://www.regulations.gov/#!documentDetail;D=EPA-HQOPPT-2007-0531-0715 as of June 13, 2013)

Algal Inhibition Test, submitted for C1 requirement on April 23, 2013 (available online 

at http://www.regulations.gov/#!documentDetail;D=EPA-HQ-OPPT-2007-0531-0716 as 

of June 13, 2013)

Acute Toxicity in the Rat – Up and Down Procedure, submitted for D testing requirement 

on March 19, 2013 (available online at 

http://www.regulations.gov/#!documentDetail;D=EPA-HQ-OPPT-2007-0531-0710 as of 

June 13, 2013)

Reverse mutation assay “Ames test” using Salmonella typhimurium and Escherichia coli, 

submitted for E1 testing requirement on December 18, 2012 (available online at 

http://www.regulations.gov/#!documentDetail;D=EPA-HQ-OPPT-2007-0531-0688 as of 

June 13, 2013)2

Micronucleus Test in the Mouse, submitted for E2 testing requirement on March 7, 2013 

(available online at http://www.regulations.gov/#!documentDetail;D=EPA-HQ-OPPT2007-0531-0709 as of June 13, 2013)

 

1 U.S. EPA. (2012) Estimation Programs Interface SuiteTM (EPI Suite) for Microsoft® Windows, v4.11. U.S. 

Environmental Protection Agency, Washington, DC, USA. Available online at 

http://www.epa.gov/opptintr/exposure/pubs/episuitedl.htm as of June 13, 2013.

2 Harcros Chemical, Inc. submitted an amendment to this study report on May 22, 2013 via email from A.M. Savini 

(Harcros Chemicals, Inc.) to J. Schaeffer (EPA) that indicated that formulated concentrations used in Experiments 1 

and 2 were adjusted for water content (49.5%).
Final HPV2 Chemical Data Adequacy Review (June 2013) CASRN 31138-65-5

2

These newly submitted data are evaluated for adequacy herein. No other toxicity data are 

evaluated in this report. 

B. EVALUATING DATA ADEQUACY

Data available for SIDS toxicity endpoints are evaluated for adequacy in Section D. Each study 

was summarized according to a standard format and assigned a Klimisch reliability code based 

on its scientific merit and conduct, using professional judgment. To determine whether data 

were adequate to satisfy SIDS endpoints, study details were compared to current standard test 

guidelines to establish whether the study met current testing requirements. Studies for a 

common endpoint are grouped together in the document and an endpoint adequacy assessment is 

provided near the top of the first page of the summaries for that endpoint. If the data available 

for the endpoint were determined to be inadequate, a basis for that conclusion is supplied. A 

table summarizing data availability/adequacy for each SIDS endpoint is included on the last page 

of this document (Section E).

C. SUMMARY OF DATA ADEQUACY FOR TESTING REQUIRED BY TEST RULE

Data supplied in the submissions identified above are adequate to satisfy the toxicity to plants 

(algae) (component of C1), acute mammalian toxicity (D), gene mutation (E1), and 

chromosomal aberrations (E2) test requirements promulgated in the final HPV2 test rule. 

However, data submitted for the acute toxicity to fish endpoint (component of C1) are not 

considered adequate to satisfy the HPV2 test rule requirement for this endpoint. This study is 

not adequate for the following reasons:

 

(1) The pH of test solution preparations in the definitive test was adjusted to 7 prior to the

addition of test organisms. This pH adjustment altered the toxicity of the test solutions, 

as evidenced by the fact that toxicity (3/3 fish killed in extremis after 3 hours of 

exposure) was observed in the range-finding test at 889 mg a.i./L without pH adjustment, 

but no toxicity was observed in the definitive test at 889 mg a.i./L when pH was adjusted 

to 7. Any toxicity resulting from a change in pH caused by the test substance is 

considered to be essential to understanding the toxic effects of the test substance. The 

results produced by the definitive study are not representative of the toxicity of the 

unaltered test substance. 

(2) The test item was boiled prior to preparation of test solutions. According to the study 

author, boiling was intended to remove any crystals that had formed. However, boiling 

the test substance may have caused the test substance to react and form other chemical 

substances. Because the chemical composition of the boiled test substance is unknown, it 

is unclear whether the test organisms were exposed to CASRN 31138-65-5 or a different 

chemical substance.1

 

1 Although the study report included a report describing analytical measurements of test substance concentrations 

(Appendix 2: Analytical Investigations), this report is incomplete. In order to determine whether or not the 

chemical identity of the test substance was changed upon boiling, the submitter would need to provide the mass 

spectrum that corresponds to the peak shown in the chromatogram.
Final HPV2 Chemical Data Adequacy Review (June 2013) CASRN 31138-65-5

3

(3) The analytical measurements of the test substance ranged from 57 to 184% of nominal 

concentrations. Given the large variation in measurements, the endpoint values (LC50, 

LOEC, and NOEC) should be based on the mean measured, rather than nominal, 

concentrations. 

Therefore, the submitter needs to repeat the acute toxicity to fish test, implementing the 

correct procedures to avoid the deficiencies identified above.

Data have not yet been submitted for the following toxicity testing requirements: acute toxicity 

to Daphnia study (component of C1 required testing) and combined repeated-dose toxicity study 

with the reproduction/developmental toxicity screening test (F1 testing). A study plan for these 

endpoints was submitted by Harcros Chemicals, Inc. on July 29, 2011 (available online at 

http://www.regulations.gov/#!documentDetail;D=EPA-HQ-OPPT-2007-0531-0639 as of June 

13, 2013).
Final HPV2 Chemical Data Adequacy Review (June 2013) CASRN 31138-65-5

4

D. DATA FOR SIDS ENDPOINTS

D-1. Acute Toxicity to Fish

Summary of endpoint: Not adequate

Study 1: 96-Hour acute toxicity study in rainbow trout (Harris, 2013) 

Title: Sodium Glucoheptonate: Acute Toxicity to Rainbow Trout (Oncorhynchus mykiss)

This study is: Adequate Not Adequate

This study is not adequate for the following reasons: 

(1) The pH of test solution preparations in the definitive test was adjusted to 7 prior to the 

addition of test organisms. This pH adjustment altered the toxicity of the test solutions, 

as evidenced by the fact that toxicity (3/3 fish killed in extremis after 3 hours of 

exposure) was observed in the range-finding test at 889 mg a.i./L without pH adjustment, 

but no toxicity was observed in the definitive test at 889 mg a.i./L when pH was adjusted 

to 7. Any toxicity resulting from a change in pH caused by the test substance is 

considered to be essential to understanding the toxic effects of the test substance. The 

results produced by the definitive study are not representative of the toxicity of the 

unaltered test substance. 

(2) The test item was boiled prior to preparation of test solutions. According to the study 

author, boiling was intended to remove any crystals that had formed. However, boiling 

the test substance may have caused the test substance to react and form other chemical 

substances. Because the chemical composition of the boiled test substance is unknown, it 

is unclear whether the test organisms were exposed to CASRN 31138-65-5 or a different 

chemical substance.1

(3) The analytical measurements of the test substance ranged from 57 to 184% of nominal 

concentrations. Given the large variation in measurements, the endpoint values (LC50, 

LOEC, and NOEC) should be based on the mean measured, rather than nominal, 

concentrations. 

TEST SUBSTANCE 

Identity: D-gluco-heptonic acid, monosodium salt, (2.xi.)- (synonym: sodium glucoheptonate); 

CASRN 31138-65-5

Remarks: Dark brown liquid; Batch No. 921000100; purity reported as 49.5% (with 50.5% 

water) in study report; however, in emails from A.M. Savini (Harcros Chemicals, Inc.) to J. 

Schaeffer (EPA) on March 5, 2013 and May 14, 2013, the composition of the test substance was 

reported as follows: 

 

1 Although the study report included a report describing analytical measurements of test substance concentrations 

(Appendix 2: Analytical Investigations), this report is incomplete. In order to determine whether or not the 

chemical identity of the test substance was changed upon boiling, the submitter would need to provide the mass 

spectrum that corresponds to the peak shown in the chromatogram.
Final HPV2 Chemical Data Adequacy Review (June 2013) CASRN 31138-65-5

5

23.4% Beta Sodium Glucoheptonate (CASRN 30090-50-3

1

)

20.62% Alpha Sodium Glucoheptonate (CASRN 13007-85-7)

6.88% Polysaccharides or Degradation Products

2.84 ppm Cyanide

1038 ppm Ammonia

49.1% Water

pH = 9.62

Specific Gravity = 1.28

% Solids = 50.9%

No dextrose detected

The above composition is identical to that provided by Harcros Chemicals, Inc. in its proposal 

for testing, available at online at http://www.regulations.gov/#!documentDetail;D=EPA-HQOPPT-2007-0531-0639 as of June 10, 2013. Based on this information, the purity of the test 

substance was 44.02% a.i.2(23.4% beta sodium glucoheptonate + 20.62% alpha sodium 

glucoheptonate).

METHOD

Method/guideline followed: OECD TG 203 (1992; “Fish, Acute Toxicity Test”), Method C.1 

of Commission Regulation (EC) No. 440/2008, and OPPTS 850.1075 (“Fish Acute Toxicity 

Test, Freshwater and Marine”)

Test type: Acute Fish Toxicity Test (Semi-Static)

GLP compliant?: Yes

Year study was performed: 2013

Test species: Rainbow trout (Oncorhynchus mykiss) obtained from Brow Well Fisheries 

Limited, located in Hebden, near Skipton, Yorkshire, UK. Fish were acclimatized to test 

conditions for at least 10 days prior to exposure. The definitive test fish were juveniles that had a 

mean standard length of 4.3 cm and a mean weight of 0.91 g at the end of the test. 

Analytical monitoring: Yes, only at the highest concentration (889 mg a.i./L) in the definitive 

test

Exposure duration: 96 hours 

Concentrations tested: Nominal concentrations: 0, 202, 364, 647, 1131, and 2020 mg test 

item/L; Concentrations adjusted for 44.02% purity: 0, 89, 160, 284, 498, and 889 mg a.i./L. 3

 

1

30090-50-3 is not a valid CAS number according to the U.S. National Library of Medicine’s ChemIDplus website 

(http://chem.sis.nlm.nih.gov/chemidplus/); however, based on the chemical name provided (beta sodium 

glucoheptonate), this component is assumed to be a stereoisomer of CASRN 31138-65-5.

2 Active ingredient (a.i.) = CASRN 31138-65-5

3 The study author erroneously reported equivalent concentrations of 100, 180, 320, 560, and 1000 mg a.i./L, 

respectively, based on an incorrect purity of 49.5%. The correct test substance purity was 44.02%.
Final HPV2 Chemical Data Adequacy Review (June 2013) CASRN 31138-65-5

6

Test method/conditions remarks:

Test water: “Laboratory tap water was dechlorinated by passage through an activated carbon 

filter (Purite Series 500) and partly softened (Elga Nimbus 1248D Duplex Water Softener) 

giving water with a total hardness of approximately 140 mg/L as CaCO3.” [Harris 2013, pp. 10]

“At the start of the definitive test the diluent had a particulate matter concentration of 0.1 mg/L, 

total water hardness of 144 mg/L CaCO3, alkalinity of 101.2 mg/L as CaCO3, Total Organic 

Carbon content of less than the limit of quantitation, determined to be 1.0 mg C/L, chemical 

oxygen demand of 2.09 mg O2/L and conductivity of 438 μS/cm. The chlorine content ranged 

from 0.000 to 0.091 mg Cl2/L.” [Harris 2013, p. 11]

Range-Finding Test Procedure: 

Two range-finding tests were conducted to determine test concentrations for the definitive test. 

For the range-finding tests, the test item was dissolved directly in dechlorinated tap water. In the 

first test, fish were exposed to 2020 mg test item/L (889 mg a.i./L). Mortalities were observed at 

this concentration and, therefore, a second range-finding test was conducted. 

In the second range-finding test, fish were exposed to 2.02, 20.22, or 202.02 mg test item/L 

(0.89, 8.9, and 89 mg a.i./L, respectively). 

“In the range-finding test 3 fish were added to each 20 liter test and control vessel and 

maintained at 13°C to 14°C in a temperature controlled room with a photoperiod of 16 hours 

light and 8 hours darkness with 20 minute dawn and dusk transition periods for a period up to 96 

hours under static test conditions.” [Harris 2013, p. 11]

“The control groups were maintained under identical conditions but not exposed to test item.

Each vessel was covered to reduce evaporation. After 3, 6, 24, 48, 72 and 96 hours any 

mortalities or sub-lethal effects of exposure were determined by visual inspection of the test 

fish.” [Harris 2013, pp. 11-12]

“A sample of each test concentration was taken for chemical analysis at 0 and 24 hours in order 

to determine the stability of the test item under test conditions. All samples were stored at 

approximately -20°C prior to analysis.” [Harris 2013, p. 12] Measured concentrations were 

reported only for nominal concentrations of 0.89 to 89 mg a.i./L.

“The analytical methodology was not validated prior to the analysis of range-finding samples; 

full validation was later conducted specifically at the test concentrations employed in the 

definitive test.” [Harris 2013, p. 28]

Definitive Test Procedure: 

Based on the results of the range-finding tests, the concentrations used in the definitive test were 

0, 89, 160, 284, 498, and 889 mg a.i./L. 
Final HPV2 Chemical Data Adequacy Review (June 2013) CASRN 31138-65-5

7

“For the purpose of the definitive test the test item was dissolved directly in dechlorinated tap 

water. Prior to weighing, the test item was boiled to remove any crystals that had formed.”

[Harris 2013, p. 12]

“Amounts of test item (4040, 72721, 12930, 22626 and 40400 mg) were dissolved in 

dechlorinated tap water and the volume adjusted to 20 liters... The test media [were] stirred with 

a flat bladed mixer to ensure complete dissolution. Prior to addition of the test animals, the pH 

of the test media was adjusted to pH 7.” [Harris 2013, p. 12]

“As in the range-finding tests, 20 liter glass exposure vessels were used for each test 

concentration. At the start of the test 10 fish were placed in each test vessel at random, in the test 

preparations. The test vessels were then covered to reduce evaporation and maintained at 13°C 

to 14°C in a temperature controlled room with a photoperiod of 16 hours light and 8 hours 

darkness with 20 minute dawn and dusk transition periods for a period of 96 hours. The test 

vessels received no auxiliary aeration. The fish were not individually identified and received no

food during exposure.” [Harris 2013, p. 12] 

“The control group was maintained under identical conditions but not exposed to the test item.”

[Harris 2013, p. 12]

“A semi-static test regime was employed in the test involving a daily renewal of the test 

preparations to ensure that the concentrations of the test item remained near nominal and to 

prevent the build up of nitrogenous waste products.” [Harris 2013, p. 12]

“Any mortalities and sub-lethal effects of exposure were recorded at 3, 6, 24, 48, 72 and 96 

hours after the start of exposure. The criteria of death were taken to be the absence of both 

respiratory movement and response to physical stimulation.” [Harris 2013, p. 13]

“The water temperature, pH and dissolved oxygen concentrations were recorded daily 

throughout the test. The measurements at 0 hours, and after each test media renewal at 24, 48 

and 72 hours, represent those of freshly prepared test preparations while the measurements taken 

prior to each test media renewal, and on termination of the test after 96 hours, represent those of 

the used or 24-Hour old test preparations. The pH and oxygen were measured using a Hach 

HQ30d Flexi handheld meter and the temperature was measured using a Hanna Instruments HI 

93510 digital thermometer. The temperature was also monitored in the control hourly using a 

Testo temperature logger.” [Harris 2013, p. 13]

Measurement of Test Concentrations: 

“Water samples were taken from the control and all surviving test groups at 0 (fresh media), 24, 

48, [and] 72 (old and fresh media) and 96 (fresh media) hours for quantitative analysis. The 

samples were stored at approximately -20°C prior to analysis.” [Harris 2013, p. 13]

“Duplicate samples were taken and stored at approximately -20°C for further analysis if 

necessary. Only samples of the NOEC [i.e., 889 mg a.i./L] were analyzed.” [Harris 2013, p. 13]

Analysis of test substance concentrations in test solutions was conducted using HPLC-MS.
Final HPV2 Chemical Data Adequacy Review (June 2013) CASRN 31138-65-5

8

RESULTS

Endpoint value(s): 96-hour LC50 > 2020 mg test item/L (> 889 mg a.i./L); 96-hour LOEC 

(survival) > 2020 mg test item/L (> 889 mg a.i./L); 96-hour NOEC (survival) = 2020 mg test 

item/L (889 mg a.i./L)

Results remarks: 

Range-Finding Test Results:

No mortalities were observed at 0, 0.89, 8.9, or 89 mg a.i./L. At the highest test concentration 

(889 mg a.i./L): “After 3 hours all of the fish were observed to have a loss of equilibrium. Due 

to approach of the substantial severity limit (Animals (Scientific Procedures) Act 1986) these 

fish were killed and classed as mortalities at the 3 hour time point.” [Harris 2013, p. 17]

Analytical measurements of the test substance in the 0.89, 8.9, or 89 mg a.i./L test preparations at 

0 and 24 hours ranged from 99% to 126% of nominal concentrations.

Definitive Test Results:

No mortalities and no sublethal effects were observed in the definitive test at nominal 

concentrations up to 889 mg a.i./L. 

“In the initial range finding test, mortalities were observed at [889 mg a.i./L]... Due to a 

technical oversight the pH of the test preparations was not adjusted to within specification. 

Adjustments to pH were made during the definitive test and hence it was considered likely that 

the mortalities observed in the initial range finding test were due to a pH effect rather than a true 

toxic effect.”1[Harris 2013, p. 15]

Throughout the test, the 89 and 160 mg a.i./L test preparations were observed to be light yellow 

solutions, increasing in color with concentration, and the 284, 498, and 889 mg a.i./L test 

preparations were observed to be dark brown solutions, increasing in color with concentration.

Physico-Chemical Measurements:

“The water temperature which was... recorded in the control vessel approximately every hour 

using a Testo temperature logger... ranged from 12°C to 14°C.”2[Harris 2013, p. 15]

Daily water temperature measurements, measured every 24 hours in old and fresh test media at 

all test concentrations, ranged from 13 to 14°C. The pH was 6.9-7.4, while dissolved oxygen 

was 8.3-11.4 mg/L (81- 111% saturation).

“The oxygen concentration in some of the test vessels was observed to have an air saturation 

value (ASV) in excess of 100%. This was considered to be due to the presence of microscopic 

air bubbles in the media super-saturating the diluent and was considered to not have had an 

 

1 While the study author considers the pH effect to not be a “true” toxic effect, EPA disagrees. Any toxicity 

resulting from a change in pH caused by the test substance is considered by EPA to be a true toxic effect. 

2 Contradicting information is shown in Figure 1 of Harris (2013), which shows continuous temperature 

measurements ranging from approximately 10 to 14 °C.
Final HPV2 Chemical Data Adequacy Review (June 2013) CASRN 31138-65-5

9

impact on the outcome or integrity of the test as no adverse effects were observed in the control 

group.” [Harris 2013, p. 15]

Verification of Test Concentrations: 

“Analysis of the... [second set of duplicate samples taken for analysis of test substance 

concentration] at 0, 24, 48, 72 and 96 hours showed measured test concentrations [at the highest 

test concentration] to range from 91% to 114% of nominal [with one exception] and so the 

results are based on nominal test concentrations only. The fresh test preparation at 48 hours was 

measured to be 184% of nominal, however, as the corresponding old preparation at 72 hours was 

near nominal it is considered that this result is anomalous and has no impact on the outcome of 

the test.” [Harris 2013, pp. 15-16]

The first set of duplicate samples analyzed for test substance concentration showed measured test 

concentrations ranging from 57 to 95% of nominal concentrations. The study author did not 

provide an explanation for the discrepancy between the two sets of samples.

CONCLUSIONS

The 96-hour LC50 for rainbow trout was greater than 889 mg a.i./L. Additionally, the 96-hour 

LOEC and NOEC were greater than 889 mg a.i./L and equal to 889 mg a.i./L, respectively.

STUDY RELIABILITY

[3] Not reliable. This study is not reliable for the following reasons:

(1) The pH of test solution preparations in the definitive test was adjusted to 7 prior to the 

addition of test organisms. This pH adjustment altered the toxicity of the test solutions, 

as evidenced by the fact that toxicity (3/3 fish killed in extremis after 3 hours of 

exposure) was observed in the range-finding test at 889 mg a.i./L without pH adjustment, 

but no toxicity was observed in the definitive test at 889 mg a.i./L when pH was adjusted 

to 7. Any toxicity resulting from a change in pH caused by the test substance is 

considered to be essential to understanding the toxic effects of the test substance. The 

results produced by the definitive study are not representative of the toxicity of the 

unaltered test substance.

(2) The test item was boiled prior to preparation of test solutions. According to the study 

author, boiling was intended to remove any crystals that had formed. However, boiling 

the test substance may have caused the test substance to react and form other chemical 

substances. Because the chemical composition of the boiled test substance is unknown, it 

is unclear whether the test organisms were exposed to CASRN 31138-65-5 or a different 

chemical substance.1

(3) The analytical measurements of the test substance ranged from 57 to 184% of nominal 

concentrations. Given the large variation in measurements, the endpoint values (LC50, 

 

1 Although the study report included a report describing analytical measurements of test substance concentrations 

(Appendix 2: Analytical Investigations), this report is incomplete. In order to determine whether or not the 

chemical identity of the test substance was changed upon boiling, the submitter would need to provide the mass 

spectrum that corresponds to the peak shown in the chromatogram.
Final HPV2 Chemical Data Adequacy Review (June 2013) CASRN 31138-65-5

10

LOEC, and NOEC) should be based on the mean measured, rather than nominal, 

concentrations. 

REFERENCE

Harris, S. (2013) Sodium glucoheptonate: Acute toxicity to rainbow trout (Oncorhynchus 

mykiss). Performing Laboratory: Harlan Laboratories Ltd., Shardlow, Derbyshire, UK. Study 

No. 41104694. Sponsor: Harcros Chemicals, Inc., Dalton, GA.

Text in quotes is taken directly from Harris (2013).
Final HPV2 Chemical Data Adequacy Review (June 2013) CASRN 31138-65-5

11

D-2. Toxicity to Aquatic Plants

Summary of endpoint: Adequate

Study 1: Toxicity to Pseudokirchneriella subcapitata (Vryenhoef, 2013)

Title: Sodium Glucoheptonate: Algal Inhibition Test 

This study is: Adequate Not Adequate

TEST SUBSTANCE 

Identity: D-gluco-heptonic acid, monosodium salt, (2.xi.)- (synonym: sodium glucoheptonate); 

CASRN 31138-65-5

Remarks: Dark brown liquid; Batch No. 921000100; purity reported as 49.5% (with 50.5% 

water) in study report; however, in emails from A.M. Savini (Harcros Chemicals, Inc.) to J. 

Schaeffer (EPA) on March 5, 2013 and May 14, 2013, the composition of the test substance was 

reported as follows: 

23.4% Beta Sodium Glucoheptonate (CASRN 30090-50-3

1

)

20.62% Alpha Sodium Glucoheptonate (CASRN 13007-85-7)

6.88% Polysaccharides or Degradation Products

2.84 ppm Cyanide

1038 ppm Ammonia

49.1% Water

pH = 9.62

Specific Gravity = 1.28

% Solids = 50.9%

No dextrose detected

The above composition is identical to that provided by Harcros Chemicals, Inc. in its proposal 

for testing, available at online at http://www.regulations.gov/#!documentDetail;D=EPA-HQOPPT-2007-0531-0639 as of June 10, 2013. Based on this information, the purity of the test 

substance was 44.02% a.i.2(23.4% beta sodium glucoheptonate + 20.62% alpha sodium 

glucoheptonate).

METHOD

Method/guideline followed: OECD TG 201 (2006; “Freshwater Alga and Cyanobacteria, 

Growth Inhibition Test”) referenced as Method C.3 of Commission Regulation (EC) No. 

761/2009 and OPPTS 850.5400 (“Algal Toxicity, Tiers I and II”)

Test type: Toxicity Test to Freshwater Algae (Static Conditions)

 

1

30090-50-3 is not a valid CAS number according to the U.S. National Library of Medicine’s ChemIDplus website 

(http://chem.sis.nlm.nih.gov/chemidplus/); however, based on the chemical name provided (beta sodium 

glucoheptonate), this component is assumed to be a stereoisomer of CASRN 31138-65-5.

2 Active ingredient (a.i.) = CASRN 31138-65-5
Final HPV2 Chemical Data Adequacy Review (June 2013) CASRN 31138-65-5

12

GLP compliant?: Yes

Year study was performed: 2012

Test species: Green algae (Pseudokirchneriella subcapitata), strain CCAP 278/4, were obtained 

from Culture Collection of Algae and Protozoa (CCAP), SAMS Research Services Ltd. in 

Argyll, Scotland. 

Analytical monitoring: Yes (at 0 and 96 hours)

Exposure duration: 96 hours

Concentrations tested: Nominal concentrations adjusted for 44.02% purity: ~ 0, 8.9, 28, 89, 

284, and 889 mg a.i./L1

Test method/conditions remarks: 

The culture medium used in both the range-finding and definitive tests had a hardness of 18 

mg/L as CaCO3 and a Total Organic Carbon (TOC) content of less than 1.0 mg C/L. 

Range-finding Test Procedure: 

In the range-finding test, Pseudokirchneriella subcapitata cells were exposed to a series of 

nominal test concentrations of 0.89, 8.9, 89, and 889 mg a.i./L for 96 hours.2

“The test was conducted in 250 mL glass conical flasks each containing 100 mL of test 

preparation and plugged with polyurethane foam bungs to reduce evaporation. Two replicate 

flasks were used for each control and test concentration. The test item was dissolved directly in 

culture medium.” [Vryenhoef 2013, p. 11]

To prepare the stock solution of 889 mg a.i./L, 1010 mg of test item was dissolved in culture 

medium and the volume adjusted to 500 mL. A series of dilutions was made to give solutions of 

0.89, 8.9, and 89 mg a.i./L. An aliquot (450 mL) of each solution was inoculated with algal 

suspension (9.7 mL).

“The stock solutions and each of the prepared concentrations were inverted several times to 

ensure adequate mixing and homogeneity.” [Vryenhoef 2013, p. 11]

“The control group was maintained under identical conditions but not exposed to the test item.”

[Vryenhoef 2013, p. 11]

 

1 The study author reported nominal concentrations of 0, 10, 32, 100, 320, and 1000 mg a.i./L, which were 

calculated based on a purity of 49.5% (water content of 50.5%). The correct test substance purity was 44.02%. The 

concentrations presented in the text above have been corrected for 44.02% purity.

2 The study author reported nominal concentrations of 1.0, 10, 100 and 1000 mg a.i./L, which were calculated based 

on an incorrect purity of 49.5% (water content of 50.5%). The correct test substance purity was 44.02%. The 

concentrations presented in the text above have been corrected for 44.02% purity.
Final HPV2 Chemical Data Adequacy Review (June 2013) CASRN 31138-65-5

13

“At the start of the range-finding test a sample of each test and control culture was removed and 

the cell density determined using a Coulter® Multisizer Particle Counter. The flasks were then 

plugged with polyurethane foam bungs and incubated (INFORS Multitron® Version 2 incubator) 

at 24 ± 1°C under continuous illumination (intensity approximately 7000 lux) provided by warm 

white lighting (380 – 730 nm) and constantly shaken at approximately 150 rpm for 96 hours.”

[Vryenhoef 2013, p. 11]

“After 96 hours the cell density of each flask was determined using a Coulter® Multisizer Particle 

Counter.” [Vryenhoef 2013, p. 12]

“A sample of each test concentration was taken for chemical analysis at 0 and 96 hours in order 

to determine the stability of the test item under test conditions. All samples were stored at 

approximately -20°C prior to analysis.” [Vryenhoef 2013, p. 12]

“The analytical methodology was not validated prior to the analysis of range-finding samples; 

full validation was later conducted specifically over the test concentration range to be employed

in the definitive test.” [Vryenhoef 2013, p. 43]

Definitive Test Procedure: 

Based on the results of the range-finding test, concentrations of 8.9, 28, 89, 284, and 889 mg 

a.i./L were chosen for the definitive test.1

To prepare the 889 and 284 mg a.i./L stock solutions, respectively, 2020 and 646 mg of the test 

item were dissolved in 1 L of culture medium. A series of dilutions was made from these stock 

solutions to give solutions of 8.9, 28, and 89 mg a.i./L. An aliquot (900 mL) of each solution 

was inoculated with algal suspension (13.5 mL).

“The stock solutions and each of the prepared concentrations were inverted several times to 

ensure adequate mixing and homogeneity.” [Vryenhoef 2013, p. 12]

“The concentration and stability of the test item in the test preparations were verified by 

chemical analysis at 0 and 96 hours.” [Vryenhoef 2013, p. 12]

Analysis of test substance concentrations in test solutions was conducted using HPLC-MS.

“As in the range-finding test 250 mL glass conical flasks were used. Six flasks each containing 

100 mL of test preparation were used for the control and three flasks each containing 100 mL 

were used for each treatment group.” [Vryenhoef 2013, p. 12]

”The control group was maintained under identical conditions but not exposed to the test item.” 

[Vryenhoef 2013, p. 12]

 

1 The study author reported nominal concentrations of 10, 32, 100, 320 and 1000 mg a.i./L, which were calculated 

based on an incorrect purity of 49.5% (water content of 50.5%). The correct test substance purity was 44.02%. The 

concentrations presented in the text above have been corrected for 44.02% purity.
Final HPV2 Chemical Data Adequacy Review (June 2013) CASRN 31138-65-5

14

“Pre-culture conditions gave an algal suspension in log phase growth characterized by a cell 

density of 6.68 x 105cells per mL. Inoculation of 900 mL of test medium with 13.5 mL of this 

algal suspension gave an initial nominal cell density of 1 x 104cells per mL and had no 

significant dilution effect on the final test concentration.” [Vryenhoef 2013, p. 12]

“The flasks were plugged with polyurethane foam bungs and incubated (INFORS Multitron®

Version 2 incubator) at 24 ± 1°C under continuous illumination (intensity approximately 7000 

lux) provided by warm white lighting (380 – 730 nm) and constantly shaken at approximately 

150 rpm for 96 hours.” [Vryenhoef 2013, pp. 12-13]

“Samples were taken at 0, 24, 48, 72 and 96 hours and the cell densities determined using a 

Coulter® Multisizer Particle Counter.” [Vryenhoef 2013, p. 13]

“At the request of the Sponsor, at the start of the test the pH of the control and test preparations 

was adjusted to pH 7. The pH of the control and each test preparation was determined at 

initiation of the test and after both 48 and 96 hours exposure... The temperature within the 

incubator was recorded hourly...” [Vryenhoef 2013, p. 13]

Re-growth Test Procedure: 

“A re-growth test was performed after 96 hours to determine the algicidal or algistatic effect of 

the test item. Aliquots were removed from each replicate control and test culture (0.25 mL and 

0.50 mL respectively) and the replicates pooled. Fresh sterile culture medium (100 mL) was 

added to each to ensure that the test concentration was reduced to below the inhibiting level.”

[Vryenhoef 2013, p. 13]

“The flasks were plugged with polyurethane foam bungs are incubated (INFORS Multitron®

Version 2 incubator) at 24 ± 1 °C under continuous illumination (intensity approximately 7000 

lux) and constantly shaken at approximately 150 rpm for 120 hours.” [Vryenhoef 2013, p. 13]

Statistical Analysis: 

“One way analysis of variance incorporating Bartlett’s test for homogeneity of variance... and 

Dunnett’s multiple comparison procedure for comparing several treatments with a control... was 

carried out on the growth rate, yield and biomass integral data after 72 and 96 hours for the 

control and all test concentrations to determine any statistically significant differences between 

the test and control groups. All statistical analyses were performed using the SAS computer 

software package (SAS 1999-2001).” [Vryenhoef 2013, pp. 15-16]

Validation Criteria:

The results of the test were considered valid if the following criteria were met:

The cell concentration in control cultures increased by a factor of at least 16 after 72 

hours and a factor of at least 100 after 96 hours.

The mean coefficient of variation of the section-by-section specific growth rates in 

controls during 0-72 hours did not exceed 35%.

The coefficient of variation of the average specific growth rate in controls did not exceed 

7% after 72 hours.
Final HPV2 Chemical Data Adequacy Review (June 2013) CASRN 31138-65-5

15

The coefficient of variation of the cell density measurements in controls did not exceed 

20% after 72 and 96 hours.

RESULTS

Endpoint value(s): The following results were determined from the data based on nominal 

concentrations: 1

Growth Rate:

72-hour ErC50 = 454 mg a.i./L*

72-hour NOEC = 28 mg a.i./L; 72-hour LOEC = 89 mg a.i./L

96-hour ErC50 = 703 mg a.i./L*

96-hour NOEC = 89 mg a.i./L; 96-hour LOEC = 284 mg a.i./L

Yield:

72-hour EyC50 = 133 mg a.i./L (95% confidence limits: 107-169 mg a.i./L)

72-hour NOEC = 28 mg a.i./L; 72-hour LOEC = 89 mg a.i./L

96-hour EyC50 = 196 mg a.i./L (95% confidence limits: 160-231 mg a.i./L)

96-hour NOEC = 8.9 mg a.i./L; 96-hour LOEC = 28 mg a.i./L

Biomass:

72-hour EbC50 = 142 mg a.i./L (95% confidence limits: 125-169 mg a.i./L)

72-hour NOEC = 28 mg a.i./L; 72-hour LOEC = 89 mg a.i./L

96-hour EbC50 = 160 mg a.i./L (95% confidence limits: 125-187 mg a.i./L)

96-hour NOEC = 28 mg a.i./L; 96-hour LOEC = 89 mg a.i./L

* 95% Confidence limits not calculable

Results remarks: 

Range-Finding Test Results:

No effects on growth rate were observed at 0.89 and 8.9 mg a.i./L. Growth rates were reduced at 

89 and 889 mg a.i./L (4 and 49% inhibition, respectively) compared to controls. Mean inhibition 

of yield and biomass was 3, 12, 22, and 93% at test concentrations of 0.89, 8.9, 89, and 889 mg 

a.i./L, respectively, relative to controls.

Measured test substance concentrations of the 8.9, 89, and 889 mg a.i./L test solutions at 0 and 

96 hours ranged from 87% to 129% of nominal concentrations. Results were not reported for the 

0.89 mg a.i./L test solutions.

Definitive Test Results: 

After 72 hours, mean inhibition of growth rate, relative to controls, was 1, 1, 7, 32, and 75% at 

test concentrations of 8.9, 28, 89, 284, and 889 mg a.i./L, respectively; effects on growth rate 

 

1 The study author reported endpoint values based on an incorrect purity of 49.5% (water content of 50.5%). The 

correct test substance purity was 44.02%. The endpoint values presented in the text above have been corrected for 

44.02% purity.
Final HPV2 Chemical Data Adequacy Review (June 2013) CASRN 31138-65-5

16

were significant (P < 0.5) at concentrations ≥ 89 mg a.i./L after 72 hours. After 96 hours, mean 

inhibition of growth rate, relative to controls, was -1, 3, 4, 18, and 60% at test concentrations of 

8.9, 28, 89, 284, and 889 mg a.i./L, respectively; effects on growth rate were significant (P < 0.5) 

at concentrations ≥ 284 mg a.i./L after 96 hours.

After 72 hours, mean inhibition of yield, relative to controls, was 6, 7, 29, 82, and 98% at test 

concentrations of 8.9, 28, 89, 284, and 889 mg a.i./L, respectively; effects on yield were 

significant (P < 0.5) at concentrations ≥ 89 mg a.i./L after 72 hours. After 96 hours, mean 

inhibition of yield, relative to controls, was -8, 13, 22, 63, and 97% at test concentrations of 8.9, 

28, 89, 284, and 889 mg a.i./L, respectively; effects on yield were significant (P < 0.5) at 

concentrations ≥ 28 mg a.i./L after 96 hours.

After 72 hours, mean inhibition of biomass, relative to controls, was 7, 9, 26, 81, and 97% at test 

concentrations of 8.9, 28, 89, 284, and 889 mg a.i./L, respectively; effects on biomass were 

significant (P < 0.5) at concentrations ≥ 89 mg a.i./L after 72 hours. After 96 hours, mean 

inhibition of biomass, relative to controls, was 1, 10, 26, 74, and 97% at test concentrations of 

8.9, 28, 89, 284, and 889 mg a.i./L, respectively; effects on biomass were significant (P < 0.5) at 

concentrations ≥ 89 mg a.i./L after 96 hours.

The test was considered valid because: the cell concentration in controls increased by a factor of 

160 after 72 hours and by a factor of 239 after 96 hours, the mean coefficient of variation for 

section-by-section specific growth rate for controls over 0-72 hours was 9%, the coefficient of 

variation for average specific growth rate for controls after 72 hours was 1%, and the coefficient 

of variation of the cell density values in replicate control cultures was 12% after 72 hours and 

3% after 96 hours.

Microscopic examination of control and test cultures at 8.9, 28, 89, and 284 mg a.i./L after 96 

hours revealed no abnormalities; however, cell debris was observed to be present at 889 mg 

a.i./L.”

Test cultures were observed to range from clear, colorless solutions at 8.9 mg a.i./L to ambercolored solutions at 889 mg a.i./L. After 96 hours, all test cultures except the 889 mg a.i./L 

cultures were observed to be green dispersions, while the 889 mg a.i./L test cultures were 

amber/green dispersions.

During the test, temperature was 24 ± 1 °C and pH ranged from 7.0 to 8.2. Prior to pH 

adjustment to 7.0 before the test began, the pH of test solutions was 7.7, 7.2, 7.4, 8.7, 9.3, and 9.6 

at concentrations of 0, 8.9, 28, 89, 284, and 889 mg a.i./L, respectively.

“Analysis of the test preparations at 0 and 96 hours showed measured test concentrations to 

range from 93% to 105% of nominal and so the results are based on nominal test concentrations 

only.” [Vryenhoef 2013, p. 7]

Regrowth Test Results: 

Regrowth was observed at 8.9, 28, 89, and 284 mg a.i./L after 48 hours and at 889 mg a.i./L after 

120 hours, indicating that the test item was algistatic.
Final HPV2 Chemical Data Adequacy Review (June 2013) CASRN 31138-65-5

17

CONCLUSIONS

The following results were determined from the data based on nominal concentrations:

The 72-hr EC50 was found to be 454 mg a.i./L for growth rate, 133 mg a.i./L for yield, and 142 

mg a.i./L for biomass. 

The 72-hour NOEC and LOEC for growth rate were 28 and 89 mg a.i./L, respectively. 

The 72-hour NOEC and LOEC for yield were 28 and 89 mg a.i./L, respectively.

The 72-hour NOEC and LOEC for biomass were 28 and 89 mg a.i./L, respectively.

The 96-hr EC50 was found to be 703 mg a.i./L for growth rate, 196 mg a.i./L for yield, and 160 

mg a.i./L for biomass. 

The 96-hour NOEC and LOEC for growth rate were 89 and 284 mg a.i./L, respectively. 

The 96-hour NOEC and LOEC for yield were 8.9 and 28 mg a.i./L, respectively.

The 96-hour NOEC and LOEC for biomass were 28 and 89 mg a.i./L, respectively.

STUDY RELIABILITY 

[2] Reliable with restrictions. The adjustment of the pH of test solution preparations to 7 at the 

start of the test may have altered the toxicity of the test solutions. However, the results of this 

test appear to be acceptable given the following: (1) Algae are relatively tolerant of a basic pH, 

such as that resulting from addition of the test substance to culture media; the effect of pH (at the 

levels resulting from test substance addition) on algal growth is not expected to appreciably 

affect the toxicity of the test solutions to algae. (2) The toxicity observed in the range-finding 

test, in which pH of test solutions appeared to be unadjusted, was similar to the toxicity observed 

in the definitive test.

REFERENCE

Vryenhoef, H. (2013) Sodium glucoheptonate: Algal inhibition test. Performing Laboratory: 

Harlan Laboratories Ltd., Shardlow, Derbyshire, UK. Study No. 41104696. Sponsor: Harcros 

Chemicals, Inc., Dalton, GA.

Text in quotes is taken directly from Vryenhoef (2013).
Final HPV2 Chemical Data Adequacy Review (June 2013) CASRN 31138-65-5

18

D-3. Acute Toxicity

Summary of endpoint: Adequate

Study 1: Acute oral toxicity study in rats (Sanders, 2013)

Title: Sodium Glucoheptonate: Acute Oral Toxicity in the Rat – Up-And-Down Procedure

This study is: Adequate Not Adequate

TEST SUBSTANCE 

Identity: D-gluco-heptonic acid, monosodium salt, (2.xi.)- (synonym: sodium glucoheptonate); 

CASRN 31138-65-5

Remarks: Dark brown liquid; Batch No. 921000100; purity reported as 49.5% in study report; 

however, in emails from A.M. Savini (Harcros Chemicals, Inc.) to J. Schaeffer (EPA) on March 

5, 2013 and May 14, 2013, the composition of the test substance was reported as follows: 

23.4% Beta Sodium Glucoheptonate (CASRN 30090-50-3

1

)

20.62% Alpha Sodium Glucoheptonate (CASRN 13007-85-7)

6.88% Polysaccharides or Degradation Products

2.84 ppm Cyanide

1038 ppm Ammonia

49.1% Water

pH = 9.62

Specific Gravity = 1.28

% Solids = 50.9%

No dextrose detected

The above composition is identical to that provided by Harcros Chemicals, Inc. in its proposal 

for testing, available at online at http://www.regulations.gov/#!documentDetail;D=EPA-HQOPPT-2007-0531-0639 as of June 10, 2013. Based on this information, the purity of the test 

substance was 44.02% a.i.2(23.4% beta sodium glucoheptonate + 20.62% alpha sodium 

glucoheptonate).

METHOD

Method/guideline followed: OECD TG 425 (2008), "Acute Oral Toxicity -

Up-and-Down-Procedure (UDP)”

Test type: Acute Oral – Rat

 

1

30090-50-3 is not a valid CAS number according to the U.S. National Library of Medicine’s ChemIDplus website 

(http://chem.sis.nlm.nih.gov/chemidplus/); however, based on the chemical name provided (beta sodium 

glucoheptonate), this component is assumed to be a stereoisomer of CASRN 31138-65-5.

2 Active ingredient (a.i.) = CASRN 31138-65-5
Final HPV2 Chemical Data Adequacy Review (June 2013) CASRN 31138-65-5

19

GLP compliant?: Yes, with exception: “No analysis was carried out to determine the 

homogeneity, concentration or stability of the test item formulation. The test item was 

formulated within two hours of being applied to the test system; it is assumed that the 

formulation was stable for this duration. This exception is considered not to affect the purpose 

or integrity of the study.” [Sanders 2013, p. 3]

Year study performed: 2012 

Test species: Female Wistar (RccHanTM:WIST strain) rats were supplied by Harlan 

Laboratories UK Ltd., located in Oxon, UK. At the start of the study, the test animals were 8 to 

12 weeks old and weighed 151 to 167 grams.

Number of animals/sex/dose: 5 females/dose

Route of administration: Oral (Gavage)

Vehicle: Distilled water

Doses/concentrations tested: Nominal doses: 354, 1112, and 4040 mg test item/kg-bw; Doses

adjusted for % active ingredient (based on 44.02% purity): 156, 490, and 1778 mg a.i./kg-bw.1

Statistical methods used: Not applicable 

Test method/conditions remarks:

“All animals were dosed once only by gavage, using a metal cannula attached to a graduated 

syringe. The volume administered to each animal was calculated according to the fasted 

bodyweight at the time of dosing. Treatment of animals was sequential. Sufficient time (at least 

48 hours) was allowed between each individual animal to confirm the outcome of the previously 

dosed animals.” [Sanders 2013, pp. 8-9]

The AOT425 Statistical Program was used to determine dose progression. The first test animal 

was administered a single dosage of 354 mg test item/kg-bw (corresponding to 156 mg a.i./kgbw). Following the first test animal, test animals 2, 3, 4, and 5 received sequential doses of 

1112, 4040, 4040 and 4040 mg test item/kg-bw, respectively (490, 1778, 1778, and 1778 mg 

a.i./kg-bw, respectively). Testing was complete when test animals 3, 4, and 5 survived the 

maximum dose level of 4040 mg test item/kg-bw (1778 mg a.i./kg-bw). 

“The animals were observed for deaths or overt signs of toxicity 1⁄2, 1, 2 and 4 hours after dosing 

and subsequently once daily for fourteen days.” [Sanders 2013, p. 9]

“Individual body weights were recorded prior to dosing and seven and fourteen days after 

treatment.” [Sanders 2013, p. 9]

 

1 The study author erroneously reported equivalent concentrations of 175, 550, and 2000 mg a.i./kg-bw, 

respectively, based on an incorrect purity of 49.5%. The correct test substance purity was 44.02%.
Final HPV2 Chemical Data Adequacy Review (June 2013) CASRN 31138-65-5

20

“At the end of the observation period the animals were killed by cervical dislocation. All animals 

were subjected to gross pathological examination. This consisted of an external examination and 

opening of the abdominal and thoracic cavities for examination of major organs. The appearance 

of any macroscopic abnormalities was recorded. No tissues were retained.” [Sanders 2013, p. 9]

RESULTS

Endpoint value(s): LD50 > 4040 mg test item/kg-bw (> 1778 mg a.i./kg-bw)

Results remarks: At termination of this study, no mortalities had been observed. 

Clinical Observations: 

“Hunched posture was noted in the animal treated at a dose level of 1112 mg [test item]/kg [490 

mg a.i./L]... No other signs of systemic toxicity were noted.” [Sanders 2013, p. 10]

Bodyweight: 

“Animals showed expected gains in bodyweight over the study period, except for one animal 

treated at a dose level of 4040 mg [test item]/kg [1778 mg a.i./L]... which showed expected gain 

in bodyweight during the first week but no gain in bodyweight during the second week.”

[Sanders 2013, p. 10]

Necropsy:

“No abnormalities were noted at necropsy.” [Sanders 2013, p. 10]

CONCLUSIONS

“The acute oral median lethal dose (LD50) of the test item in the female Wistar strain rat was 

found to be greater than 4040 mg [test item]/kg bodyweight [1778 mg a.i./L]...” [Sanders 2013, 

p. 11]

STUDY RELIABILITY

[2] Reliable with restrictions. The maximum dose of 1778 mg a.i./kg-bw employed in this study 

is somewhat less than the maximum dose of 2000 mg/kg-bw recommended by the test guideline 

specified by the HPV2 test rule (40 CFR 799.9110(d)(1)(i)(A) or OECD TG 425) in the absence 

of mortality. 

REFERENCES

Sanders, A. (2013) Sodium glucoheptonate: Acute oral toxicity in the rat – up-and-down 

procedure. Performing Laboratory: Harlan Laboratories Ltd., Shardlow, Derbyshire, UK. 

Project No. 41104687. Sponsor: Harcros Chemicals, Inc., Dalton, GA. 

Text in quotes is taken directly from Sanders (2013).
Final HPV2 Chemical Data Adequacy Review (June 2013) CASRN 31138-65-5

21

D-4. Genetic Toxicity – Gene Mutation

Summary of endpoint: Adequate 

Study 1: Reverse mutation assay in Salmonella typhimurium and Escherichia coli

(Thompson, 2012)

Title: Sodium glucoheptonate: Reverse mutation assay “Ames test” using Salmonella

typhimurium and Escherichia coli

This study is: Adequate Not Adequate

TEST SUBSTANCE 

Identity: D-gluco-heptonic acid, monosodium salt, (2.xi.)- (synonym: sodium glucoheptonate); 

CASRN 31138-65-5

Remarks: Dark brown liquid; Batch No. 921000100; purity reported as 50.5% (with 49.5% 

water) in study report; however, in an email from A.M. Savini (Harcros Chemicals, Inc.) to J. 

Schaeffer (EPA) on March 5, 2013, the composition of the test substance was reported as 

follows: 

23.4% Beta Sodium Glucoheptonate (CASRN 30090-50-3

1

)

20.62% Alpha Sodium Glucoheptonate (CASRN 13007-85-7)

6.88% Polysaccharides or Degradation Products

2.84 ppm Cyanide

1038 ppm Ammonia

49.1%Water

pH = 9.62

Specific Gravity = 1.28

% Solids = 50.9%

No dextrose detected 

The above composition is identical to that provided by Harcros Chemicals, Inc. in its proposal 

for testing, available at online at http://www.regulations.gov/#!documentDetail;D=EPA-HQOPPT-2007-0531-0639 as of June 10, 2013. Based on this information, the purity of the test 

substance was 44.02% a.i.2(23.4% beta sodium glucoheptonate + 20.62% alpha sodium 

glucoheptonate).

 

1

30090-50-3 is not a valid CAS number according to the U.S. National Library of Medicine’s ChemIDplus website 

(http://chem.sis.nlm.nih.gov/chemidplus/); however, based on the chemical name provided (beta sodium 

glucoheptonate), this component is assumed to be a stereoisomer of CASRN 31138-65-5.

2 Active ingredient (a.i.) = CASRN 31138-65-5
Final HPV2 Chemical Data Adequacy Review (June 2013) CASRN 31138-65-5

22

METHOD

Method/guideline followed: OECD TG 471 (“Bacterial Reverse Mutation Test”); EU Method 

B13/14 of Commission Regulation (EC) number 440/2008; and the USA EPA (TSCA) OPPTS 

harmonized guidelines.

Test type: Bacterial Reverse Mutation Test

GLP compliant?: Yes, with exception: “No analysis was carried out to determine the 

homogeneity, concentration or stability of the test item formulation. The test item was 

formulated within four hours of it being applied to the test system. It is assumed that the 

formulation was stable for this duration. This exception is considered not to affect the purpose 

or integrity of the study.” [Thompson, 2012, p. 3]

Year study performed: 2012

Test species: Salmonella typhimurium strains TA1535, TA1537, TA98 and TA100; Escherichia 

coli strain WP2uvrA

Metabolic activation: With and without (rat liver S9 homogenate)

Concentrations tested: 44, 131, 436, 1308, and 4358 μg a.i./plate1

Statistical methods used: According to Mahon, G.A.T. et al. (1989) Analysis of data from 

microbial colony assays. In: Statistical Evaluation of Mutagenicity Test Data, UKEMS subcommittee on guidelines for mutagenicity testing, (Kirkland, D. J., Ed.), Cambridge University 

Press Report, 26-65.

Test method/conditions remarks: The mutagenicity assay was conducted by exposing 

Salmonella typhimurium tester strains TA1535, TA1537, TA98, and TA100, and Escherichia 

coli strain WP2uvrA with and without an exogenous metabolic activating system, rat liver 

homogenate. S9 fractions were derived from rats induced orally with phenobarbitone/βnaphthoflavone orally for three days. Sterile distilled water was used as a vehicle for the test 

substance. All test solutions were used within 4 hours of preparation. The concentrations for the 

first experiment were determined by a preliminary toxicity assay, in which nominal tested 

concentrations were reported as 0, 0.15, 0.5, 1.5, 5, 15, 50, 150, 500, 1500, and 5000 μg/plate2in 

S. typhimurium strain TA100 and E. coli strain WP2uvrA using the plate incorporation method 

with and without metabolic activation. No toxicity was observed in the preliminary toxicity test.

 

1 The study author reported concentrations of 0, 50, 150, 500, 1500, and 5000 μg/plate, which were calculated by 

adjusting for a purity of 50.5% (water content of 49.5%). The correct test substance purity was 44.02%. The 

concentrations presented in the text above have been corrected for 44.02% purity.

2 The study report does not indicate whether the concentrations reported for the preliminary toxicity test are adjusted 

for % purity of the test substance.
Final HPV2 Chemical Data Adequacy Review (June 2013) CASRN 31138-65-5

23

In experiment 1, concentrations of 44, 131, 436, 1308, and 4358 μg a.i./plate1 were assayed in 

triplicate for each tester strain, using the direct plate incorporation method. Experiment 2 tested 

the same concentrations as experiment 1, in triplicate for each tester strain, using the preincubation test method.

All of the plates were incubated at 37°C for ~48 hours and revertant colonies were counted using 

an automated colony counter.

A solvent treatment group was used as the vehicle control; positive controls without S9-mix 

included N-ethyl-N’-nitro-N-nitrosoguanidine (2 μg/plate for WP2uvrA, 3 μg/plate for TA100, 

and 5 μg/plate for TA1535), 9-aminoacridine (80 μg/plate for TA1537), and 4-nitroquinoline-1-

oxide (0.2 μg/plate for TA98). Additionally, 2-aminoanthracene (1 μg/plate for TA100, 2 

μg/plate for TA1535 and TA1537, and 10 μg/plate for WP2uvrA) and benzo(a)pyrene (5 

μg/plate for TA98), which are non-mutagenic in the absence of metabolizing enzymes, were 

used as positive controls with S9-mix. 

The test article was evaluated as positive if: a dose-related increase in mutant frequency 

occurred over the dose range tested, a reproducible increase occurred at one or more 

concentrations, biological relevance against in-house historical ranges was seen, statistical 

analysis of data as determined by UKEMS proved significant, and/or an increase of greater than 

two-fold occurred as compared to the concurrent solvent control for any tester strain. The test 

item response was evaluated as negative if the above criteria were not met. An equivocal result 

would be reported when an experiment did not give a clear positive or negative result.

RESULTS

Genotoxicity result: Negative in the presence and absence of metabolic activation

Cytotoxic concentration (if applicable): > 4358 μg a.i./plate

Results remarks: In the preliminary toxicity test, the test item was non-toxic to both strains of 

bacteria used (TA100 and WP2uvrA).

No visible reduction in the growth of the bacterial background lawn was observed at any 

concentration tested in any of the tests. No test item precipitate was observed at any of the 

concentrations tested in either the presence or absence of S9-mix.

“No significant increases in the frequency of revertant colonies were recorded for any of the 

bacterial strains, with any dose of the test item, either with or without metabolic activation or [by 

either] exposure method.” [Thompson, 2012, p. 16]

 

1 The study author reported concentrations of 0, 50, 150, 500, 1500, and 5000 μg/plate, which were calculated by 

adjusting for a purity of 50.5% (water content of 49.5%). The correct test substance purity was 44.02%. The 

concentrations presented in the text above have been corrected for 44.02% purity.
Final HPV2 Chemical Data Adequacy Review (June 2013) CASRN 31138-65-5

24

Solvent controls tested concurrently responded appropriately. Positive controls induced marked 

increases in the frequency of revertant colonies, confirming the activity of the S9-mix and the 

sensitivity of the bacterial strains.

CONCLUSIONS

“The test item, Sodium Glucoheptonate, was considered to be non-mutagenic under the 

conditions of this test.” [Thompson, 2012, p. 16]

STUDY RELIABILITY

[2] Reliable with restrictions. The maximum concentration of 4358 μg a.i./plate employed in 

this study is somewhat less than the maximum concentration of 5000 μg/plate recommended for 

soluble non-cytotoxic substances by test guidelines 40 CFR 799.9510 (guideline specified by the 

HPV2 test rule) and OECD TG 471 (guideline followed according to the study report). 

REFERENCES

Thompson, PW. (2012) Sodium glucoheptonate: Reverse mutation assay “Ames test” using 

Salmonella typhimurium and Escherichia coli. Performing Laboratory: Harlan Laboratories 

Ltd., Shardlow, Derbyshire, UK. Project number: 41104688. Sponsor: Harcros Chemicals Inc., 

Dalton, GA.1 

Text in quotes is taken directly from Thompson (2012). 

 

1 Harcros Chemical, Inc. submitted an amendment to this study report on May 22, 2013 via email from A.M. Savini 

(Harcros Chemicals, Inc.) to J. Schaeffer (EPA) that indicated that formulated concentrations used in Experiments 1 

and 2 were adjusted for water content (49.5%).
Final HPV2 Chemical Data Adequacy Review (June 2013) CASRN 31138-65-5

25

D-5. Genetic Toxicity – Chromosomal Aberrations

Summary of endpoint: Adequate 

Study 1: In vivo mouse micronucleus assay (Flanders, 2013)

Title: Sodium Glucoheptonate: Micronucleus Test in the Mouse 

The study is: Adequate Not Adequate

TEST SUBSTANCE 

Identity: D-gluco-heptonic acid, monosodium salt, (2.xi.)- (synonym: sodium glucoheptonate); 

CASRN 31138-65-5

 

Remarks: Dark brown liquid; Batch No. 921000100; purity reported as 50.5% (with 49.5% 

water) in study report; however, in emails from A.M. Savini (Harcros Chemicals, Inc.) to J. 

Schaeffer (EPA) on March 5, 2013 and May 14, 2013, the composition of the test substance was 

reported as follows: 

23.4% Beta Sodium Glucoheptonate (CASRN 30090-50-3

1

)

20.62% Alpha Sodium Glucoheptonate (CASRN 13007-85-7)

6.88% Polysaccharides or Degradation Products

2.84 ppm Cyanide

1038 ppm Ammonia

49.1% Water

pH = 9.62

Specific Gravity = 1.28

% Solids = 50.9%

No dextrose detected

The above composition is identical to that provided by Harcros Chemicals, Inc. in its proposal 

for testing, available at online at http://www.regulations.gov/#!documentDetail;D=EPA-HQOPPT-2007-0531-0639 as of June 10, 2013. Based on this information, the purity of the test 

substance was 44.02% a.i.2(23.4% beta sodium glucoheptonate + 20.62% alpha sodium 

glucoheptonate).

METHOD

Method/guideline followed: OECD TG 474 (1997; “Mammalian Erythrocyte Micronucleus 

Test”), Method B12 of Commission Regulation (EC) No. 440/2008 (2008), OPPTS 870.5395 

(1998; “In vivo Mammalian Cytogenetics Tests: Erythrocyte Micronucleus Assay”), and 

Japanese METI/MHLW/MAFF Guidelines 

 

1

30090-50-3 is not a valid CAS number according to the U.S. National Library of Medicine’s ChemIDplus website 

(http://chem.sis.nlm.nih.gov/chemidplus/); however, based on the chemical name provided (beta sodium 

glucoheptonate), this component is assumed to be a stereoisomer of CASRN 31138-65-5.

2 Active ingredient (a.i.) = CASRN 31138-65-5
Final HPV2 Chemical Data Adequacy Review (June 2013) CASRN 31138-65-5

26

Test type: In vivo Mouse Micronucleus Assay 

GLP compliant?: Yes, with exception: “No analysis was carried out to determine the 

homogeneity, concentration or stability of the test item formulation. The test item was 

formulated within two hours of it being applied to the test system; it is assumed that the 

formulation was stable for this duration. This exception is considered not to affect the purpose 

or integrity of the study.” [Flanders 2013, p. 3]

Year study performed: 2012

Test species: Albino Hsd: ICR (CD-1

®

) mice were obtained from Harlan Laboratories UK Ltd., 

located in Oxon, UK. Prior to testing, the test animals were approximately 6 to 10 weeks old and 

weighed 21 to 30 grams.

Metabolic activation: Not applicable

Number of animals/sex/dose: 7 males/dose

Route of administration: Range-finding: oral (gavage) or intraperitoneal (i.p.); Definitive: 

intraperitoneal

Vehicle: Phosphate buffered saline (PBS)

Doses/concentrations tested: 0 (vehicle only), 436, 872, and 1743 mg a.i./kg-bw1 

Statistical methods used: “All data were statistically analysed using appropriate statistical 

methods as recommended by the UKEMS Sub-committee on Guidelines for Mutagenicity 

Testing Report, Part III (1989). The data was analysed following a transformation 

using Student’s t-test (two tailed) and any significant results were confirmed using the one way 

analysis of variance.” [Flanders 2013, p. 13]

Test method/conditions remarks:

“For the purpose of this study the test item was freshly prepared as required as a solution at the 

appropriate concentration in phosphate buffered saline (PBS).” [Flanders 2013, p. 8]

Range-Finding Study Procedure: 

“A range-finding toxicity test was performed to determine a suitable dose level and route of 

administration for the micronucleus test. The dose level selected should ideally be the maximum 

tolerated dose level or that which produces some evidence of toxicity up to a maximum 

recommended dose of 2000 mg/kg. The range-finding toxicity test was also used to determine if 

the main test was to be performed using both sexes or males only. With no evidence of toxicity 

via the oral route, and following discussions with the Sponsor, it was considered necessary to 

 

1 The study author reported doses of 0, 500, 1000, and 2000 mg/kg-bw, which were calculated by adjusting for a

purity of 50.5% (water content of 49.5%). The correct test substance purity was 44.02%. The concentrations 

presented in the text above have been corrected for 44.02% purity.
Final HPV2 Chemical Data Adequacy Review (June 2013) CASRN 31138-65-5

27

investigate the intraperitoneal route of administration to maximise exposure of the test item.”

[Flanders 2013, p. 10]

In the range-finding tests, groups of mice were dosed as follows:

1/sex at 1743 mg a.i./kg-bw (oral)

1/sex at 872 mg a.i./kg-bw (i.p.)

1/sex at 1308 mg a.i./kg-bw (i.p.)

3 males and 1 female at 1743 mg a.i./kg-bw (i.p.)

“All animals were dosed once only at the appropriate dose level [using a dose volume of 10 

mL/kg] by gavage using a metal cannula or a hypodermic needle attached to a graduated syringe. 

The volume administered to each animal was calculated according to its bodyweight at the time 

of dosing.” [Flanders 2013, p. 11]

“Animals were observed one hour after dosing and subsequently once daily for up to two days. 

Any deaths and evidence of overt toxicity were recorded at each observation. No necropsies 

were performed.” [Flanders 2013, p. 11]

Main Test Procedure: 

Male mice received a single dose of the test item via the intraperitoneal route at 436, 872, or 

1743 mg a.i./kg-bw using a dose volume of 10 mL/kg. Groups of 7 animals were dosed at 436 

and 872 mg a.i./kg-bw and 14 animals were dosed at 1743 mg a.i./kg-bw. Seven of the animals 

at the high dose were killed by cervical dislocation 24 hours following treatment and the 

remaining animals were killed after 48 hours. 

“Two additional groups of male mice were included in the study; one group (seven mice) was 

dosed via the intraperitoneal route with the vehicle alone (PBS) and a second group (five mice) 

was dosed orally with cyclophosphamide [at 50 mg/kg-bw]. Cyclophosphamide is a positive 

control item known to produce micronuclei under the conditions of the test. The vehicle and 

positive control group animals were killed 24 hours following dosing.” [Flanders 2013, p. 11]

“Animals were observed for signs of overt toxicity and death one hour after dosing and then once 

daily as applicable and immediately prior to termination.” [Flanders 2013, p. 12]

Slide Preparation: 

“Immediately following termination (i.e. 24 or 48 hours following dosing), both femurs were 

dissected from each surviving animal, aspirated with foetal bovine serum and bone marrow 

smears prepared following centrifugation and re-suspension. The smears were air-dried, fixed in 

absolute methanol, stained in May-Grünwald/Giemsa, allowed to air-dry and a cover slip applied 

using mounting medium.” [Flanders 2013, p. 12]

Slide Evalution: 

“Stained bone marrow smears were coded and examined blind using light microscopy at x1000 

magnification. Where possible, the incidence of micronucleated cells per 2000 polychromatic 

erythrocytes (PCE-blue stained immature cells) per animal was scored. Micronuclei are 

normally circular in shape, although occasionally they may be oval or half-moon shaped, and 
Final HPV2 Chemical Data Adequacy Review (June 2013) CASRN 31138-65-5

28

have a sharp contour with even staining. In addition, the number of normochromatic 

erythrocytes (NCE-pink stained mature cells) associated with 1000 erythrocytes was counted; 

these cells were also scored for incidence of micronuclei.” [Flanders 2013, pg. 12]

“The ratio of polychromatic to normochromatic erythrocytes was calculated together with 

appropriate group mean values and standard deviations.” [Flanders 2013, p. 13]

Criteria for a Positive Response: 

“A comparison was made between the number of micronucleated polychromatic erythrocytes 

occurring in each of the test item groups and the number occurring in the vehicle control group.” 

[Flanders 2013, p. 13]

“A positive mutagenic response would be demonstrated when a statistically significant, doseresponsive, toxicologically relevant increase in the number of micronucleated polychromatic 

erythrocytes was observed for either the 24 or 48-hour kill times when compared to the vehicle 

control group.” [Flanders 2013, p. 13]

“If these criteria were not fulfilled, then the test item would be considered non-genotoxic under 

these conditions of the test.” [Flanders 2013, p. 13]

“A positive response for bone marrow toxicity would be demonstrated when the dose group 

mean polychromatic to normochromatic ratio was shown to be statistically significantly lower 

than the vehicle control group.” [Flanders 2013, p. 13]

RESULTS

Genotoxicity result: Negative 

Cytotoxic concentration (if applicable): > 1743 mg a.i./kg-bw (i.p.)

Results remarks: 

Range-Finding Study Results: 

No mortalities occurred during the range-finding study. 

No clinical signs were observed in animals dosed with the test item at 1743 mg a.i./kg-bw via the 

oral route. “Therefore, with no evidence of toxicity [via the oral route] the intraperitoneal route 

of administration was investigated to maximise exposure of the test item.” [Flanders 2013, p. 

14]

Animals dosed intraperitoneally with the test substance at ≥ 872 mg a.i./kg-bw showed clinical 

signs of hunched posture, ptosis, increased activity, and irritation and over-grooming of the 

injection site (incidence data for each dose level were not reported). This was considered to be

evidence of modest toxicity. The dose levels chosen for the main test were 436, 872, and 1743 

mg a.i./kg-bw. Since there was no marked difference in the toxicity observed in males and 

females, the main test was performed using male mice only. 
Final HPV2 Chemical Data Adequacy Review (June 2013) CASRN 31138-65-5

29

Main Test Results: 

No unscheduled deaths occurred in any of the dose groups in the main test. Clinical signs 

observed in animals dosed with the test item at ≥ 872 mg a.i./kg-bw in both the 24 and 48-hour 

dose groups included hunched posture and ptosis (incidence data for each dose level were not 

reported). 

“Statistically significant decreases in the PCE/NCE ratio were not observed in any of the test 

item dose groups when compared to the vehicle control group. However, the observation of 

clinical signs was taken to indicate that systemic absorption had occurred and exposure to the 

target tissue had been achieved.” [Flanders 2013, p. 15]

“There was no evidence of any statistically significant increases in the incidence of 

micronucleated polychromatic erythrocytes in animals dosed with the test item when compared 

to the vehicle control group.” [Flanders 2013, p. 15]

“The positive control group showed a marked increase in the incidence of micronucleated 

polychromatic erythrocytes hence confirming the sensitivity of the system to the known 

mutagenic activity of cyclophosphamide under the conditions of the test.” [Flanders 2013, p. 15]

CONCLUSIONS

“The test item was found not to produce a toxicologically significant increase in the frequency of 

micronuclei in polychromatic erythrocytes of mice under the conditions of the test.” [Flanders 

2013, p. 15]

STUDY RELIABILITY

[2] Reliable with restrictions. The study report did not include incidence data on clinical signs 

observed in the main study (i.e., hunched posture and ptosis) or the range-finding study (i.e., 

hunched posture, ptosis, increased activity, and irritation and over-grooming of the injection site)

in animals dosed via the intraperitoneal route at 889 mg a.i./kg-bw and above. 

REFERENCE

Flanders, L. (2013) Sodium glucoheptonate: Micronucleus test in the mouse. Performing 

Laboratory: Harlan Laboratories Ltd., Shardlow, Derbyshire, UK. Project No. 41104690. 

Sponsor: Harcros Chemicals, Inc., Dalton, GA.

Text in quotes is taken directly from Flanders (2013).
Final HPV2 Chemical Data Adequacy Review (June 2013) CASRN 31138-65-5

30

E. DATA ADEQUACY SUMMARY TABLE

Endpoint Study Information 

Available

Acceptable Data Gap

Aquatic Effects

Acute Toxicity to Fish Yes No Yes

Acute Toxicity to Aquatic 

Invertebrates

No – Yes

Toxicity to Aquatic Plants Yes Yes No

Health Effects

Acute Toxicity Yes Yes No

Repeated-Dose Toxicity No – Yes

Gene Mutation Yes Yes No

Chromosomal Aberrations Yes Yes No

Reproductive Toxicity No – Yes

Developmental Toxicity No – Yes